Jacques Bernier, Genolier and Geneva
Manjit Dosanjh, CERN
Kian K. Ang (Pre-Clinical Strategies)
Ugo Amaldi (New Technologies)
Michael Baumann (Pre-Clinical Strategies)
Soeren M. Bentzen (Radiotherapy)
Jacques Bernier
Sergio Bertolucci
Jean Bourhis (Clinical Perspectives)
Jean-François Chatal (Nuclear Medicine)
Alberto Del Guerra (Detectors and Imaging)
Manjit Dosanjh
Marco Durante (Biology)
Wolfgang Enghardt (Detectors and Imaging)
Zvi Fuks (Clinical Perspectives)
Ulli Köster (Nuclear Medicine)
W. Gillies McKenna (Biology)
Rahde Mohan (Radiotherapy)
Steve Myers
Ken Peach (New Technologies)
Brad Wouters
Members of the Advisory Board are in bold
Biology | Detectors and Imaging | |
M. Durante, Darmstadt | W. Enghardt, Dresden | |
W.G. Mc Kenna, Oxford | A. Del Guerra, Pisa | |
J.M. Brown, Stanford | S. Bertolucci, CERN | |
B. Jones, Oxford | P.Lecoq, CERN | |
B. Wouters, Toronto | D. Townsend, Singapore | |
Pre-clinical Strategies | Nuclear Medicine | |
K.K. Ang, Houston | J.F. Chatal, Nantes | |
M. Baumann, Dresden | U. Köster, Grenoble | |
M. Verheij, Amsterdam | D. Lewis (CERN) | |
New Technologies | Radiotherapy | |
U. Amaldi, TERA | S.M. Bentzen, Madison | |
K. Peach, Oxford | R. Mohan, Houston | |
S. Rossi, Milano | D.R. Olsen, Oslo | |
T. Haberer, Heidelberg | S. Korreman, Copenhagen | |
Clinical Perspectives | ||
J. Bourhis, Villejuif | Z. Fuks, New-York | |
J. Bernier, Genolier and Geneva | D. Brizel, Durham |